Aptamer Group PLC (AIM:APTA)
0.900
0.00 (0.00%)
At close: Mar 6, 2026
Aptamer Group Revenue
In the fiscal year ending June 30, 2025, Aptamer Group had annual revenue of 1.20M GBP with 39.88% growth. Aptamer Group had revenue of 550.00K in the half year ending June 30, 2025, a decrease of -25.37%.
Revenue
1.20M
Revenue Growth
+39.88%
P/S Ratio
20.18
Revenue / Employee
38.81K
Employees
31
Market Cap
24.27M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SkinBioTherapeutics | 4.64M |
| Arecor Therapeutics | 5.06M |
| Fusion Antibodies | 1.60M |
| ImmuPharma | -69.96K |
| Oxford BioDynamics | 1.10M |
| Ondine Biomedical | 1.18M |
| hVIVO | 54.47M |
Aptamer Group News
- 2 months ago - Aptamer Enters Licensing Agreement With Alphazyme - Nasdaq
- 5 months ago - Full Year 2025 Aptamer Group PLC Earnings Presentation Transcript - GuruFocus
- 5 months ago - AIM Market Roundup: HSS Hire, Aptamer, EQTEC - The Armchair Trader
- 6 months ago - Aptamer Group launches biomarker discovery service to expand revenue base - The Armchair Trader
- 7 months ago - UK Stock Market News: Aptamer, MicroSalt, HICL - The Armchair Trader
- 7 months ago - AIM Market Roundup: Westmount Energy, Aptamer, Europa Oil & Gas - The Armchair Trader
- 1 year ago - Half Year 2025 Aptamer Group PLC Earnings Presentation Transcript - GuruFocus